"Risks and Rewards: The Truth About New Alzheimer's Drugs"
TL;DR
Scientists are warning against the approval of drugs like lecanemab and donanemab for Alzheimer's disease, citing risks such as brain shrinkage, swelling, and bleeding. While these drugs claim to slow cognitive decline by clearing out amyloid protein, they have been associated with serious side effects, including fatal outcomes and significant brain volume loss. The marginal improvement in cognitive function does not outweigh the potential harm, raising concerns about the utility of these treatments.
Topics:healthhealth-medicine#alzheimers-disease#brain-shrinkage#cognitive-decline#dementia#drug-side-effects#health-medicine
- Scientists Warn Against ‘Miracle’ Alzheimer’s Drugs, Say They Cause Shrinkage, Swelling, Bleeding Of The Brain SaharaReporters.com
- Alzheimer's disease: Animal study looks at potential new treatment Medical News Today
- 'Revolutionary' Alzheimer's drugs could have fatal side-effects The Times
- 'Miracle' Alzheimer's drugs could be shrinking the brains of patients, experts warn Daily Mail
- BBC Panorama captures the promise and challenges of new Alzheimer's treatments Alzheimer's Research UK
Want the full story? Read the original reporting
Read on SaharaReporters.com